Mendelsohn E E, Solum N O, Brosstad F
Research Institute for Internal Medicine, University of Oslo, Rikshospitalet, Norway.
Scand J Clin Lab Invest. 2005;65(4):321-32. doi: 10.1080/00365510510025719.
The Cephotest is an activated partial thromboplastin time (APTT) test used to measure the activity of the intrinsic pathway of coagulation. To perform this test, blood is usually centrifuged to obtain plasma that is almost without erythrocytes and leucocytes and with only a minimal amount of platelets.
In the present experiments blood was centrifuged at different speeds to produce either platelet-poor plasma (PPP) or platelet-rich plasma (PRP). PPP and PRP obtained from the same whole blood samples from each of several persons were tested in pairs using the standard Cephotest reagent to observe the consequences of Cephotest being performed on plasma containing platelets. The same procedure was used with a Cephotest reagent with a reduced concentration of phosphatidylserine. In succeeding experiments the PRP was preincubated with SFLLRN or Ca-ionophore to activate the platelets, a procedure also known to produce platelet-derived microparticles. PPP and PRP were compared by thrombin time and reptilase time tests to find out at which stage platelets might influence the Cephotest.
The results showed that the platelets did influence Cephotest when using both the regular reagent and the phospholipid-reduced agent. When using the regular reagent, PRP showed a tendency towards a longer APTT than PPP. It is suggested that this was caused by platelets consuming some of the first traces of thrombin generated.
When using the phospholipid-reduced reagent, PRP showed a shorter APTT than PPP, probably because the platelets contributed phosphatidylserine to the system. When the platelets were activated before testing, their effects on the tests were increased. Microparticles that formed during platelet activation may have contributed to these effects.
塞弗托测试(Cephotest)是一种活化部分凝血活酶时间(APTT)测试,用于测量内源性凝血途径的活性。进行该测试时,通常将血液离心以获得几乎不含红细胞和白细胞且仅含极少量血小板的血浆。
在本实验中,将血液以不同速度离心以产生贫血小板血浆(PPP)或富血小板血浆(PRP)。从几个人的每份全血样本中获得的PPP和PRP使用标准塞弗托测试试剂成对进行测试,以观察在含血小板的血浆上进行塞弗托测试的结果。对磷脂酰丝氨酸浓度降低的塞弗托测试试剂采用相同程序。在后续实验中,将PRP与SFLLRN或钙离子载体预孵育以激活血小板,这一过程也已知会产生血小板衍生微粒。通过凝血酶时间和爬虫酶时间测试比较PPP和PRP,以找出血小板可能影响塞弗托测试的阶段。
结果表明,使用常规试剂和磷脂减少试剂时血小板确实会影响塞弗托测试。使用常规试剂时,PRP的APTT有比PPP更长的趋势。这表明这是由血小板消耗了产生的最初微量凝血酶所致。
使用磷脂减少试剂时,PRP的APTT比PPP短,可能是因为血小板向系统中贡献了磷脂酰丝氨酸。在测试前激活血小板时,它们对测试的影响会增强。血小板激活过程中形成的微粒可能促成了这些影响。